Relmada Therapeutics Inc (RLMD) Insider Trading
- $1,725,768.28
- $9,744,532.36
- May 20, 2025
- Maged Shenouda
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 12, 2018 | Director | 150,000 | $0.90 | Buy | $135,000.00 | |
| Dec. 16, 2015 | Director | 1,100 | $3.43 | Buy | $3,773.00 | |
| Dec. 15, 2015 | CEO | 18,970 | $3.05 | Buy | $57,858.50 | |
| Dec. 15, 2015 | Director | 3,000 | $2.99 | Buy | $8,970.00 |
Insiders are both buying and selling Relmada Therapeutics Inc stock.
The insider traders at Relmada Therapeutics Inc are: Maged Shenouda, Sergio Traversa, Paul Edward Kelly, Charles J Casamento, Chuck Ence, Shreeram Agharkar, Charles J. Casamento, and Cedric O'gorman
The most active insider trader at Relmada Therapeutics Inc is Maged Shenouda with 16 trades.
Paul Edward Kelly has sold the most Relmada Therapeutics Inc stock with a total value of $7,428,324.00.
Sergio Traversa has bought the most Relmada Therapeutics Inc stock with a total value of $858,773.56.
The most recent insider trade for Relmada Therapeutics Inc was on May 20, 2025.
The single biggest insider buy for Relmada Therapeutics Inc was from Sergio Traversa with a total value of $153,706.93 on Sept. 11, 2024.
The single biggest insider sell for Relmada Therapeutics Inc was from Paul Edward Kelly with a total value of $6,388,263.00 on Jan. 22, 2021.